Jesse Shefferman Protara Therapeutics, Inc. (TARA) insider trading activity

Jesse Shefferman is CEO and President of Protara Therapeutics, Inc.. Currently has a direct ownership of 959,886 shares of TARA, which is worth approximately $3.04 Million. The most recent transaction as insider was on Jun 27, 2025, when has been sold 13,567 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 960K

3.43% 3M change

1.68% 12M change

Total Value Held $3.04 Million

Jesse Shefferman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 27 2025	SELL Bona fide gift	-	13,567 Reduced 1.39%	959,886 Common Stock
Jun 26 2025	SELL Bona fide gift	-	5,100 Reduced 0.52%	973,453 Common Stock
Jun 24 2025	SELL Bona fide gift	-	300,000 Reduced 31.25%	659,886 Common Stock
Jan 24 2025	BUY Grant, award, or other acquisition	-	65,000 Added 6.14%	994,022 Common Stock
Jan 21 2025	SELL Payment of exercise price or tax liability	$73,632 $4.76 p/Share	15,469 Reduced 1.67%	913,553 Common Stock
Jan 03 2025	SELL Payment of exercise price or tax liability	$39,781 $6.14 p/Share	6,479 Reduced 0.69%	929,022 Common Stock
Aug 28 2024	SELL Bona fide gift	-	8,563 Reduced 0.91%	935,501 Common Stock
Jan 19 2024	SELL Payment of exercise price or tax liability	$14,903 $1.91 p/Share	7,803 Reduced 0.82%	944,064 Common Stock
Jan 19 2024	BUY Grant, award, or other acquisition	-	59,000 Added 5.84%	951,867 Common Stock
Jan 10 2024	SELL Payment of exercise price or tax liability	$13,732 $2.39 p/Share	5,746 Reduced 0.64%	892,867 Common Stock
Jan 03 2024	SELL Payment of exercise price or tax liability	$12,672 $2.17 p/Share	5,840 Reduced 0.65%	898,613 Common Stock
Jun 27 2023	SELL Bona fide gift	-	7,420 Reduced 0.81%	904,453 Common Stock
Jun 23 2023	SELL Bona fide gift	-	1,890 Reduced 0.21%	911,873 Common Stock
Jan 19 2023	BUY Grant, award, or other acquisition	-	51,300 Added 5.29%	918,282 Common Stock
Jan 10 2023	SELL Payment of exercise price or tax liability	$17,565 $3.0 p/Share	5,855 Reduced 0.67%	866,982 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$18,491 $2.8 p/Share	6,604 Reduced 0.75%	872,837 Common Stock
Aug 11 2022	BUY Open market or private purchase	$34,810 $3.84 p/Share	9,065 Added 1.02%	879,441 Common Stock
Jan 10 2022	SELL Payment of exercise price or tax liability	$31,852 $6.27 p/Share	5,080 Reduced 0.58%	872,425 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	42,300 Added 4.6%	877,505 Common Stock
Jan 11 2021	SELL Payment of exercise price or tax liability	$107,260 $21.16 p/Share	5,069 Reduced 0.6%	835,205 Common Stock

Jesse Shefferman

CEO and President

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARA shares.

Notify only if

Value

Insider Trading

Get notified when an Protara Therapeutics, Inc. insider buys or sells TARA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Protara Therapeutics, Inc.

Track Activities on TARA

Account